Clinical Trial Update: Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase 1/2 study is evaluating ApoCell for the prevention of acute graft-versus-host disease. The update notes safety and preliminary efficacy asse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Malignancies

Drugs mentioned

• ApoCell

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Graft Versus Host Disease, Hematological Malignancies | Phase 1, Phase 2 | Status: UNKNOWN